# Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas

> **NCT06271603** · NA · UNKNOWN · sponsor: **Damae Medical** · enrollment: 704 (estimated)

## Conditions studied

- Basal Cell Carcinoma of the Skin

## Interventions

- **DIAGNOSTIC_TEST:** diagnosis based on deepLive™ LC-OCT device
- **DIAGNOSTIC_TEST:** diagnosis based on skin biopsy

## Key facts

- **NCT ID:** NCT06271603
- **Lead sponsor:** Damae Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-26
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 704 (ESTIMATED)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271603, "Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06271603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*